Plain-English translation of NCT07305337 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to know if an artificial intelligence robot can help patients with blood cancers—like leukemia, lymphoma, or multiple myeloma—learn more about clinical trials. Right now, many patients don't fully understand what clinical trials are or how they work. This study will compare two groups: one that receives standard hospital education, and one that also gets special education delivered by an AI robot that can talk with you and show videos and images.
Many patients with blood cancers don't know enough about clinical trials to decide whether to join one, even though trials can offer new treatment options. Researchers believe an interactive AI system might explain trials more clearly and help more patients feel confident about participating.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be placed in one of two groups. Both groups receive the hospital's normal health education about your disease and treatment. The other group also participates in special sessions with an AI robot that teaches you about how clinical trials work, what to expect, and answers common questions—using voice conversations, videos, and images to make it easier to understand. The study aims to see whether this AI education helps you feel more informed and willing to consider joining a clinical trial in the future.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China